Cargando…

Impact of selective LDL apheresis on serum chemerin levels in patients with hypercholesterolemia

BACKGROUND: Selective low-density lipoprotein (LDL) apheresis is commonly used to treat patients with familial hypercholesterolemia (FH). Chemerin is an adipokine with putative roles in the regulation of lipid metabolism. METHODS: In our pilot study, we measured serum chemerin levels by enzyme-linke...

Descripción completa

Detalles Bibliográficos
Autores principales:	Varga, Viktória E., Lőrincz, Hajnalka, Zsíros, Noémi, Fülöp, Péter, Seres, Ildikó, Paragh, György, Balla, József, Harangi, Mariann
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2016
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5069981/ https://www.ncbi.nlm.nih.gov/pubmed/27756331 http://dx.doi.org/10.1186/s12944-016-0353-x

Ejemplares similares

Association of chemerin with oxidative stress, inflammation and classical adipokines in non-diabetic obese patients
por: Fülöp, Péter, et al.
Publicado: (2014)

Serum obestatin level strongly correlates with lipoprotein subfractions in non-diabetic obese patients
por: Szentpéteri, Anita, et al.
Publicado: (2018)

Clinical Aspects of Genetic and Non-Genetic Cardiovascular Risk Factors in Familial Hypercholesterolemia
por: Berta, Eszter, et al.
Publicado: (2022)

Plasminogen Activator Inhibitor-1 Level Correlates with Lipoprotein Subfractions in Obese Nondiabetic Subjects
por: Somodi, Sándor, et al.
Publicado: (2018)

Afamin Levels and Their Correlation with Oxidative and Lipid Parameters in Non-diabetic, Obese Patients
por: Juhász, Imre, et al.
Publicado: (2022)

Determination of Serum Progranulin in Patients with Untreated Familial Hypercholesterolemia
por: Nádró, Bíborka, et al.
Publicado: (2022)

Decreased Serum Stromal Cell-Derived Factor-1 in Patients with Familial Hypercholesterolemia and Its Strong Correlation with Lipoprotein Subfractions
por: Juhász, Lilla, et al.
Publicado: (2023)

Changes in serum pigment epithelium-derived factor levels after kidney transplantation in patients with end-stage renal disease
por: Szentimrei, Réka, et al.
Publicado: (2022)

High-density lipopoprotein antioxidant capacity, subpopulation distribution and paraoxonase-1 activity in patients with systemic lupus erythematosus
por: Gaál, Krisztina, et al.
Publicado: (2016)

Gender-Dependent Associations between Serum Betatrophin Levels and Lipoprotein Subfractions in Diabetic and Nondiabetic Obese Patients
por: Lőrincz, Hajnalka, et al.
Publicado: (2023)

Sphingosine 1-Phosphate and Apolipoprotein M Levels and Their Correlations with Inflammatory Biomarkers in Patients with Untreated Familial Hypercholesterolemia
por: Juhász, Lilla, et al.
Publicado: (2022)

Low Levels of Serum Fetuin-A and Retinol-Binding Protein 4 Correlate with Lipoprotein Subfractions in Morbid Obese and Lean Non-Diabetic Subjects
por: Lőrincz, Hajnalka, et al.
Publicado: (2021)

Impaired Organokine Regulation in Non-Diabetic Obese Subjects: Halfway to the Cardiometabolic Danger Zone
por: Lőrincz, Hajnalka, et al.
Publicado: (2023)

The Potential Diagnostic and Predictive Role of HbA1c in Diabetic, Septic Patients: A Retrospective Single-Center Study
por: Juhász, Imre, et al.
Publicado: (2022)

Effects of alpha-lipoic acid treatment on serum progranulin levels and inflammatory markers in diabetic neuropathy
por: Nádró, Bíborka, et al.
Publicado: (2021)

Assessment of Associations Between Serum Lipoprotein (a) Levels and Atherosclerotic Vascular Diseases in Hungarian Patients With Familial Hypercholesterolemia Using Data Mining and Machine Learning
por: Németh, Ákos, et al.
Publicado: (2022)

Crucial Regulatory Role of Organokines in Relation to Metabolic Changes in Non-Diabetic Obesity
por: Lőrincz, Hajnalka, et al.
Publicado: (2023)

Myeloperoxidase modulation by LDL apheresis in Familial Hypercholesterolemia
por: Puntoni, Mariarita, et al.
Publicado: (2011)

Serum Cystatin C Is a Determinant of Paraoxonase Activity in Hemodialyzed and Renal Transplanted Patients
por: Varga, Éva, et al.
Publicado: (2009)

The Importance of Arterial Stiffness Assessment in Patients with Familial Hypercholesterolemia
por: Kovács, Beáta, et al.
Publicado: (2022)

HELP LDL Apheresis Reduces Plasma Pentraxin 3 in Familial Hypercholesterolemia
por: Zanetti, Michela, et al.
Publicado: (2014)

Causes, clinical findings and therapeutic options in chylomicronemia syndrome, a special form of hypertriglyceridemia
por: Paragh, György, et al.
Publicado: (2022)

LDL apheresis in a woman with severe heterozygous familial hypercholesterolemia. Late, but not too late
por: Mickiewicz, Agnieszka, et al.
Publicado: (2015)

Identifying Patients with Familial Chylomicronemia Syndrome Using FCS Score-Based Data Mining Methods
por: Németh, Ákos, et al.
Publicado: (2022)

Increased hair selenium concentration in hyperlipidemic patients
por: Fülöp, Péter, et al.
Publicado: (2013)

Familial Hypercholesterolemia and Lipoprotein Apheresis
por: Makino, Hisashi, et al.
Publicado: (2019)

The Impact of Obesity on the Cardiovascular System
por: Csige, Imre, et al.
Publicado: (2018)

LDL Apheresis and Lp (a) Apheresis: A Clinician’s Perspective
por: Kayikcioglu, Meral
Publicado: (2021)

Long-Term LDL-Apheresis Treatment and Dynamics of Circulating miRNAs in Patients with Severe Familial Hypercholesterolemia
por: Dlouha, Dana, et al.
Publicado: (2023)

An update on lipid apheresis for familial hypercholesterolemia
por: Taylan, Christina, et al.
Publicado: (2022)

LDL-Apheresis: Technical and Clinical Aspects
por: Bambauer, Rolf, et al.
Publicado: (2012)

Advanced glycation end products and their soluble receptor (sRAGE) in patients with Hashimoto’s thyroiditis on levothyroxine substitution
por: Csiha, Sára, et al.
Publicado: (2023)

Usefulness of Lipid Apheresis in the Treatment of Familial Hypercholesterolemia
por: Lui, Matthew, et al.
Publicado: (2014)

Role of Altered Metabolism of Triglyceride-Rich Lipoprotein Particles in the Development of Vascular Dysfunction in Systemic Lupus Erythematosus
por: Diószegi, Ágnes, et al.
Publicado: (2023)

Adverse Impact of Diet-Induced Hypercholesterolemia on Cardiovascular Tissue Homeostasis in a Rabbit Model: Time-Dependent Changes in Cardiac Parameters
por: Kertész, Attila, et al.
Publicado: (2013)

Beneficial effect of LDL-apheresis in refractory nephrotic syndrome
por: Muso, Eri
Publicado: (2014)

Lipoprotein-apheresis reduces circulating microparticles in individuals with familial hypercholesterolemia
por: Connolly, Katherine D., et al.
Publicado: (2014)

Establishing the Mutational Spectrum of Hungarian Patients with Familial Hypercholesterolemia
por: Madar, László, et al.
Publicado: (2022)

Changes of Metabolic Biomarker Levels upon One-Year Anti-TNF-α Therapy in Rheumatoid Arthritis and Ankylosing Spondylitis: Associations with Vascular Pathophysiology
por: Czókolyová, Monika, et al.
Publicado: (2021)

The effect of DALI lipid apheresis in the prognosis of homozygous familial hypercholesterolemia: Seven patients' experience at a DALI apheresis center
por: Bulut, Muhammet, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_0avq8ufr4bvip9e29k5epa2v31